Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting
Open Access
- 27 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-11
Abstract
Synchronous assessment of multiple MRI contrast agents in a single scanning session would provide a new “multi-color” imaging capability similar to fluorescence imaging but with high spatiotemporal resolution and unlimited imaging depth. This multi-agent MRI technology would enable a whole new class of basic science and clinical MRI experiments that simultaneously explore multiple physiologic/molecular events in vivo. Unfortunately, conventional MRI acquisition techniques are only capable of detecting and quantifying one paramagnetic MRI contrast agent at a time. Herein, the Dual Contrast – Magnetic Resonance Fingerprinting (DC-MRF) methodology was extended for in vivo application and evaluated by simultaneously and dynamically mapping the intra-tumoral concentration of two MRI contrast agents (Gd-BOPTA and Dy-DOTA-azide) in a mouse glioma model. Co-registered gadolinium and dysprosium concentration maps were generated with sub-millimeter spatial resolution and acquired dynamically with just over 2-minute temporal resolution. Mean tumor Gd and Dy concentration measurements from both single agent and dual agent DC-MRF studies demonstrated significant correlations with ex vivo mass spectrometry elemental analyses. This initial in vivo study demonstrates the potential for DC-MRF to provide a useful dual-agent MRI platform.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R21 HL130839, F30 HL136190)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA179956, R01 CA202814, P30 043703)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB023704, T32 EB007509)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM007250)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- PKD Foundation (Research Award)
- Cystic Fibrosis Foundation (Research Award)
This publication has 43 references indexed in Scilit:
- Magnetic resonance fingerprintingNature, 2013
- Multicolor two-photon tissue imaging by wavelength mixingNature Methods, 2012
- Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancerBiomaterials, 2010
- Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamineNature Biotechnology, 2010
- Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulinProceedings of the National Academy of Sciences, 2006
- High resolution pHe imaging of rat glioma using pH‐dependent relaxivityMagnetic Resonance in Medicine, 2006
- A new transgene reporter for in vivo magnetic resonance imagingNature Medicine, 2005
- Nonuniform fast fourier transforms using min-max interpolationIEEE Transactions on Signal Processing, 2003
- Proton relaxation enhancementJournal of Magnetic Resonance Imaging, 1993
- Spatial Localization in NMR Spectroscopy in VivoAnnals of the New York Academy of Sciences, 1987